Prelude Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $2.73M | Sell |
|
|||||
|
2024
Q4 | $2.28M | Sell |
|
|||||
|
2024
Q3 | $2.75M | Buy |
|
|||||
|
2024
Q2 | $2.75M | Buy |
|
|||||
|
2024
Q1 | $2.41M | Sell |
|
|||||
|
2023
Q4 | $2.79M | Buy |
|
|||||
|
2023
Q3 | $2.08M | Sell |
|
|||||
|
2023
Q2 | $2.31M | Buy |
|
|||||
|
2023
Q1 | $266K | Sell |
|
|||||
|
2022
Q4 | $385K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1.72M | Buy |
|
|||||
|
2021
Q4 | $736K | Buy |
|
|||||
|
2021
Q3 | $409K | Buy |
|
|||||
|
2020
Q3 | – | Hold |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $762K | Sell |
|
|||||
|
2019
Q4 | $1.04M | Sell |
|
|||||
|
2019
Q3 | $1.33M | Buy |
|
|||||
|
2019
Q2 | $241K | Sell |
|
|||||
|
2019
Q1 | $795K | Buy |
|
|||||
|
2018
Q4 | $100K | Sell |
|
|||||
|
2018
Q3 | $1.94M | Sell |
|
|||||
|
2018
Q2 | $5.43M | Buy |
|
|||||
|
2018
Q1 | $2.98M | Sell |
|
|||||
|
2017
Q4 | $3.56M | Buy |
|
|||||
|
2017
Q3 | $3M | Buy |
|
|||||
|
2017
Q2 | $1.97M | Buy |
|
|||||
|
2017
Q1 | $773K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $203K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $141K | Sell |
|
|||||
|
2015
Q4 | $879K | Buy |
|
|||||
|
2015
Q3 | $613K | Sell |
|
|||||
|
2015
Q2 | $751K | Sell |
|
|||||
|
2015
Q1 | $804K | Buy |
|
|||||
|
2014
Q4 | $325K | Sell |
|
|||||
|
2014
Q3 | $537K | Buy |
|
|||||
|
2014
Q2 | $378K | Sell |
|
|||||
|
2014
Q1 | $556K | Buy |
|
|||||
|
2013
Q4 | $241K | Sell |
|
|||||
|
2013
Q3 | $285K | Sell |
|
|||||
|
2013
Q2 | $652K | Buy |
|